Skip to content

Decision Aid to Technologically Enhance Shared Decision Making

Decision Aid to Technologically Enhance Shared Decision Making

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01514786
Acronym
DATES
Enrollment
570
Registered
2012-01-23
Start date
2012-05-31
Completion date
2015-04-30
Last updated
2017-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal Cancer, Screening, Prevention

Brief summary

Physicians face a challenge in promoting colorectal cancer screening (CRCS) in the face of multiple competing demands. A decision aid (DA) that clarifies patient preferences and improves decision quality could aid shared decision making (SDM) and be effective at increasing CRCS rates. However, exactly how such DA improves SDM is not clear. This 4-year R01 study funded by the National Cancer Institute seeks to provide detailed understanding of how an interactive DA affects patient-physician communication and SDM, and ultimately CRCS adherence.

Detailed description

This two-armed randomized controlled trial (300 patients/arm) will compare Colorectal Web (CW), the interactive DA, to a non-interactive control website in ten practices in Metro Detroit. Patients will be adults aged 50 years and over, not current on CRCS. In the clinic before the patient-physician encounter, participants will complete a Patient Baseline Survey. They will be randomized to CW or the control website. Data will be collected after the patient reviews the respective website (Post-Intervention Survey), during the patient-physician encounter (digital audio recording), and after it (Post-Encounter Survey). Chart audit will be performed six months after the encounter to determine whether the patient underwent CRCS.

Interventions

BEHAVIORALColorectal Web

The intervention arm will allow participants on Colorectal Web to manipulate their preferences for CRCS

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 50-75 years of age * not current with colorectal cancer screening * scheduled for HME, Health Maintenance Exam, or chronic care visit with participating physician * able to read English * current contact information

Exclusion criteria

* history of colon cancer or adenomatous polyps * history of dementia or psychosis * contraindication to CRCS

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Reporting Preferred Screening Type as Reported by Chart Audits6 months following intervention a chart audit will be conducted to determine if CRCS was completed.Chart audits were conducted 6 months after the participant's study visit to determine if screening had occurred and if the type of screen was the same as the participant's preferred type of screening.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
Same information is presented in the control website as is found in the intervention website, but no interactive component: preferences and risk assessment.
286
Intervention With Colorectal Website
Intervention website includes an interactive component including preferences and risk assessment. Colorectal Web: The intervention arm will allow participants on Colorectal Web to manipulate their preferences for CRCS
284
Total570

Baseline characteristics

CharacteristicControlIntervention With Colorectal WebsiteTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
55 Participants44 Participants99 Participants
Age, Categorical
Between 18 and 65 years
231 Participants240 Participants471 Participants
Age, Continuous58.3 years
STANDARD_DEVIATION 6.9
57.1 years
STANDARD_DEVIATION 6.8
57.7 years
STANDARD_DEVIATION 6.9
Participants screened for colon cancer111 Participants99 Participants210 Participants
Region of Enrollment
United States
286 Participants284 Participants570 Participants
Sex: Female, Male
Female
177 Participants143 Participants320 Participants
Sex: Female, Male
Male
109 Participants141 Participants250 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2861 / 284
other
Total, other adverse events
0 / 2860 / 284
serious
Total, serious adverse events
0 / 2861 / 284

Outcome results

Primary

Number of Participants Reporting Preferred Screening Type as Reported by Chart Audits

Chart audits were conducted 6 months after the participant's study visit to determine if screening had occurred and if the type of screen was the same as the participant's preferred type of screening.

Time frame: 6 months following intervention a chart audit will be conducted to determine if CRCS was completed.

ArmMeasureValue (NUMBER)
ControlNumber of Participants Reporting Preferred Screening Type as Reported by Chart Audits111 participants
Intervention With Colorectal WebsiteNumber of Participants Reporting Preferred Screening Type as Reported by Chart Audits99 participants

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026